<?xml version="1.0" encoding="UTF-8"?>
<p>Ribonucleoside (
 <bold>IV</bold>) has not been previously described. Nor has the antiviral activity of perylene compounds, in relation to other respiratory viruses, been tested previously. The aim of this work was to synthesize the ribo derivative (
 <bold>IV</bold>) and to obtain data on the antiviral activity of compounds (
 <bold>I</bold>)â€“(
 <bold>IV</bold>) in relation to the influenza A virus and two other respiratory pathogens: type 3 parainfluenza virus and respiratory syncytial virus.
</p>
